Verastem (VSTM) Cash from Investing Activities Growth (1y) (2012 - 2024)
Verastem (VSTM) Cash from Investing Activities Growth (1y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Verastem | 607.94 Mn | 410.11 Mn | 15.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 107.09% |
| Mar 31, 2024 | 3,953.11% |
| Dec 31, 2023 | -4.52% |
| Sep 30, 2023 | -1,608.05% |
| Jun 30, 2023 | -52.14% |
| Mar 31, 2023 | -104.17% |
| Dec 31, 2022 | 19,634.85% |
| Sep 30, 2022 | -53.53% |
| Jun 30, 2022 | 1,122.27% |
| Mar 31, 2022 | 255.71% |
| Dec 31, 2021 | 100.08% |
| Sep 30, 2021 | 166,766.67% |
| Jun 30, 2021 | 8,962.96% |
| Mar 31, 2021 | -138.60% |
| Dec 31, 2020 | -415.93% |
| Sep 30, 2020 | -100.03% |
| Jun 30, 2020 | -100.06% |
| Mar 31, 2020 | 8,729.20% |
| Dec 31, 2019 | 119.81% |
| Sep 30, 2019 | 213.66% |